Understand the source comparison
Best Peptides for Post Hip Replacement: Research vs Clinical Comparison
BPC-157 VEGF upregulation, anti-inflammatory cytokine modulation, fibroblast migration Inflammatory phase (weeks 0–6) 250–500mcg daily Subcutaneous (local or systemic) Animal models + case series (no RCTs) Strongest anti-inflammatory signal; best for patients
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- VEGF upregulation, anti-inflammatory cytokine modulation, fibroblast migration
- Inflammatory phase (weeks 0–6)
- 250–500mcg daily
- Subcutaneous (local or systemic)
- Animal models + case series (no RCTs)
- Strongest anti-inflammatory signal; best for patients with persistent swelling or autoimmune factors
- TB-500
- Actin upregulation, cell migration, angiogenesis, reduced fibrosis
- Proliferative phase (weeks 6–16)
- 2–5mg twice weekly, taper to weekly
- Subcutaneous (systemic)
- Animal models + observational studies
- Best for delayed soft tissue healing; superior for older patients with compromised angiogenesis
- Collagen Peptides (Type I/II)
- Direct amino acid substrate for ECM synthesis, cartilage support
- Remodeling phase (months 4–12)
- 10–15g daily
- Oral
- Multiple RCTs in joint health populations
- Only peptide with Level 1 evidence; essential for long-term structural integrity
- GHK-Cu (Copper Peptide)
- Collagen synthesis, MMP modulation, anti-inflammatory
- All phases (adjunct)
- 1–3mg daily
- Subcutaneous or topical (near incision)
- Limited orthopedic data; dermal wound healing established
- Promising but under-researched for joint surgery; primarily used for incision healing